Center for Genetic Engineering and Biotechnology (CIGB), Vaccines, Havana, Cuba.
Curr Microbiol. 2009 Dec;59(6):579-83. doi: 10.1007/s00284-009-9488-6. Epub 2009 Sep 26.
Testing in non-human primates is a generally accepted necessary step preceding the evaluation of dengue vaccine candidates in humans. A reduction of viremia in these animals after virus challenge is generally used as an indicator of vaccine efficacy. In this work, we compared the infectivity of three strains of dengue virus type 2 in a non-human primate model of dengue infection, with the aim of selecting a virus for vaccine protection studies. As a result, strain SB8553 produced the longest duration of viremia, with a mean of 3 days/animal. In addition, it induced the highest antiviral and neutralizing antibody titers. These results support the use of strain SB8553 in challenge assays in this model and demonstrate that infection of green monkeys with dengue virus type 2 is dependent on the strain of virus used.
在评估登革热候选疫苗在人类中的效果之前,用非人类灵长类动物进行试验是被广泛认可的必要步骤。在这些动物中,病毒攻击后病毒血症的减少通常被用作疫苗效果的指标。在这项工作中,我们比较了三种登革热病毒 2 型在登革热感染的非人类灵长类动物模型中的传染性,目的是选择一种病毒用于疫苗保护研究。结果表明,SB8553 株产生的病毒血症持续时间最长,平均为每只动物 3 天。此外,它还诱导了最高的抗病毒和中和抗体滴度。这些结果支持在该模型的挑战试验中使用 SB8553 株,并表明用登革热病毒 2 型感染绿猴取决于所用病毒株。